A randomized study comparing oral and standard regimens for metastatic breast cancer

  • Authors: Taisuke Hori, Hiroshi Kodama, Satoru Nishimura, Takehiko Hatano, Ryuji Okamura, Koji Fujii, Takashi Kudo, Takashi Inamoto, Kiyoshi Sawai, Masao Kobayashi, Hiroki Ogawa, Norio Yoshimura, Masahiro Hiraoka
  • View Affiliations

  • Published online on: Saturday, September 1, 2001
  • Pages: 1067-1071
  • DOI: 10.3892/or.8.5.1067

Abstract

We conducted a randomized controlled trial comparing oral regimen [doxifluridine, an intermediate metabolite of capecitabine, + medroxyprogesterone acetate (MPA) + cyclophosphamide (CPA)] (Method A) with a standard regimen (5-fluorouracil + adriamycin + CPA) plus MPA (Method B) as first line chemotherapy for metastatic breast cancer. Overall response rate was 55.8% for Method A, 46.3% for Method B. The total ratio of responder and long stable disease was significantly higher with Method A (p=0.006). Median time to progression and survival were not differences between Methods. Incidence of toxicity was 56.3% with Method A and 80.0% with Method B (p=0.014). Oral regimen is more useful than standard therapy.
Journal Cover

September 2001
Volume 8 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

2012 Impact Factor: 2.297
Ranked #36/196 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Hori, T., Kodama, H., Nishimura, S., Hatano, T., Okamura, R., Fujii, K., Kudo, T., Inamoto, T., Sawai, K., Kobayashi, M., Ogawa, H., Yoshimura, N., & Hiraoka, M. (2001). A randomized study comparing oral and standard regimens for metastatic breast cancer. Oncology Reports, 8(5), 1067-1071.
MLA
Hori, Kodama, Nishimura, Hatano, Okamura, Fujii, Kudo, Inamoto, Sawai, Kobayashi, Ogawa, Yoshimura, and Masahiro Hiraoka. "A randomized study comparing oral and standard regimens for metastatic breast cancer." Oncology Reports Oncology Reports 8.5 (2001): 1067-1071.
Chicago
Hori, Kodama, Nishimura, Hatano, Okamura, Fujii, Kudo, Inamoto, Sawai, Kobayashi, Ogawa, Yoshimura, and Masahiro Hiraoka. "A randomized study comparing oral and standard regimens for metastatic breast cancer." Oncology Reports Oncology Reports 8 no. 5 (2001): 1067-1071.